Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
5(71%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
29%
Ph phase_2
3
43%

Phase Distribution

0

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

7

all time

Status Distribution
Active(5)
Completed(2)

Detailed Status

Active, not recruiting3
Completed2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
7
Active
5
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 23 (60.0%)
N/A2 (40.0%)

Trials by Status

completed229%
recruiting229%
active_not_recruiting343%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
PROCEDURE
Total Trials
7